Literature DB >> 2757875

Findings at necropsy in the heart of a patient with anticardiolipin syndrome.

J J Murphy1, I H Leach.   

Abstract

A 40 year old man with a history of myocardial infarction and hypertension presented with transient cerebral ischaemic attacks, aortic regurgitation, a raised erythrocyte sedimentation rate, and thrombocytopenia. The anticardiolipin syndrome was diagnosed and he was treated with prednisolone and warfarin. He died two years later after the development of acute heart failure. At necropsy his heart showed widespread arteriolar thrombosis without vasculitis, recanalised large vessel occlusion, and a "post-inflammatory" valvulitis of the aortic valve.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2757875      PMCID: PMC1216732          DOI: 10.1136/hrt.62.1.61

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  10 in total

1.  Myocardial infarction in a young man with systemic lupus erythematosus, deep vein thrombosis, and antibodies to phospholipid.

Authors:  R A Asherson; I R Mackay; E N Harris
Journal:  Br Heart J       Date:  1986-08

2.  The anticardiolipin syndrome.

Authors:  G R Hughes; N N Harris; A E Gharavi
Journal:  J Rheumatol       Date:  1986-06       Impact factor: 4.666

3.  Pathogenetic potential of antiphospholipid antibodies.

Authors:  D Alarcón-Segovia
Journal:  J Rheumatol       Date:  1988-06       Impact factor: 4.666

Review 4.  Anticardiolipin antibodies--clinical associations.

Authors:  R A Asherson; E N Harris
Journal:  Postgrad Med J       Date:  1986-12       Impact factor: 2.401

5.  The Prosser-White oration 1983. Connective tissue disease and the skin.

Authors:  G R Hughes
Journal:  Clin Exp Dermatol       Date:  1984-11       Impact factor: 3.470

Review 6.  Cardiovascular manifestations of systemic lupus erythematosus: current perspective.

Authors:  A Ansari; P H Larson; H D Bates
Journal:  Prog Cardiovasc Dis       Date:  1985 May-Jun       Impact factor: 8.194

7.  Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986.

Authors:  E N Harris; A E Gharavi; S P Patel; G R Hughes
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

8.  Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results.

Authors:  S Loizou; J D McCrea; A C Rudge; R Reynolds; C C Boyle; E N Harris
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

9.  Intracardiac thrombosis, phospholipid antibodies, and two-chambered right ventricle.

Authors:  M A Coppock; R E Safford; G K Danielson
Journal:  Br Heart J       Date:  1988-11

10.  Coronary artery bypass graft failure--an autoimmune phenomenon?

Authors:  K E Morton; T P Gavaghan; S A Krilis; G E Daggard; D W Baron; J B Hickie; C N Chesterman
Journal:  Lancet       Date:  1986-12-13       Impact factor: 79.321

  10 in total
  13 in total

1.  Histological appearance of the intra-osseous vessels of the femoral head in aseptic osteonecrosis of the hip, with or without antiphospholipid antibodies.

Authors:  M Laroche; I Ludot; M Thiechart; G Viguier; C Dromer; B Mazières
Journal:  Clin Rheumatol       Date:  1997-06       Impact factor: 2.980

Review 2.  The antiphospholipid syndrome: a syndrome in evolution.

Authors:  R A Asherson; R Cervera
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

3.  Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome.

Authors:  M G Tektonidou; J P Ioannidis; I Moyssakis; K A Boki; V Vassiliou; P G Vlachoyiannopoulos; M K Kyriakidis; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  2001-01       Impact factor: 19.103

4.  Systemic lupus erythematosus complicated by tricuspid stenosis and regurgitation: successful treatment by valve transplantation.

Authors:  D E Ames; R A Asherson; J D Coltart; V Vassilikos; J K Jones; G R Hughes
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

Review 5.  Catastrophic antiphospholipid syndrome: treatment, prognosis, and the risk of relapse.

Authors:  Silvia Bucciarelli; Doruk Erkan; Gerard Espinosa; Ricard Cervera
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

Review 6.  Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview.

Authors:  Penka A Atanassova
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

7.  M mode and Doppler echocardiographic assessment of left ventricular diastolic function in primary antiphospholipid syndrome.

Authors:  N Coudray; D de Zuttere; O Blétry; J C Piette; B Wechsler; P Godeau; J C Pourny; Y Lecarpentier; D Chemla
Journal:  Br Heart J       Date:  1995-11

Review 8.  Microthrombotic/microangiopathic manifestations of the antiphospholipid syndrome.

Authors:  Sonja Praprotnik; Dusan Ferluga; Alenka Vizjak; Anastazija Hvala; Tadej Avcin; Blaz Rozman
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

Review 9.  Antiphospholipid syndrome; its implication in cardiovascular diseases: a review.

Authors:  Ioanna Koniari; Stavros N Siminelakis; Nikolaos G Baikoussis; Georgios Papadopoulos; John Goudevenos; Efstratios Apostolakis
Journal:  J Cardiothorac Surg       Date:  2010-11-03       Impact factor: 1.637

Review 10.  Cardiac Manifestations of Antiphospholipid Syndrome With Focus on Its Primary Form.

Authors:  Tamara Kolitz; Shachaf Shiber; Itzhak Sharabi; Asher Winder; Gisele Zandman-Goddard
Journal:  Front Immunol       Date:  2019-05-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.